• HyperMed has assembled a highly experienced team of medical device professionals to commercialize its hyperspectral imaging technology.

Management

Dave Johnson

Dave Johnson

Executive Chairman of the Board, HyperMed Imaging, Inc.

BIO

Mark Darty

Mark Darty

Founder, CEO, & President

BIO

Max Mortensen, PhD

Max Mortensen, PhD

SVP Operations and Chief Compliance Officer

BIO

Peter Meenen, PhD

Peter Meenen, PhD

Director of R&D
and Chief Engineer

BIO


Board of Directors

David Wetherell

David Wetherell

Managing Partner,
Biomark Capital

BIO

Douglas Lind, MD

Douglas Lind, MD

Managing Director,
Biomark Capital

BIO

Dave Johnson

Dave Johnson

Executive Chairman of the Board, HyperMed Imaging, Inc.

BIO

Mark Darty

Mark Darty

Founder, CEO, & President, HyperMed Imaging, Inc.

BIO

HyperMed’s new tissue oximetry device called HyperView™ is FDA 510(k) cleared.
HyperMed, HyperView, OxyVu™-1 and the company logo are trademarks of HyperMed Imaging, Inc.